Fluphenazine
Fluphenazine Hydrochoride
Phenothiazine
NADAC/unit
$0.2176
No Shortage
Tier 1: 165.7%
PA Req: 113.4%
22 Manufacturers
70 ANDAs
Fluphenazine treats psychotic disorders and severe nausea by blocking dopamine receptors.
vs. brand Fluphenazine Hydrochoride: Generic saves up to 98% per unit
Active Shortages
2025-09-18 Discontinuation of the manufacture of the drug., Upsher-Smith Laboratories, LLC
2025-09-18 Discontinuation of the manufacture of the drug., Upsher-Smith Laboratories, LLC
2025-09-18 Discontinuation of the manufacture of the drug., Upsher-Smith Laboratories, LLC
2025-09-18 Discontinuation of the manufacture of the drug., Upsher-Smith Laboratories, LLC
Market Intelligence
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
AJANTA PHARMA LTDALEMBIC PHARMACEUTICALS LTDAMNEAL EU LTDAUROBINDO PHARMA LTDDR REDDYS LABORATORIES INCEUGIA PHARMA SPECIALITIES LTDFRESENIUS KABI USA LLCGLAND PHARMA LTDGLENMARK PHARMACEUTICALS LTDHETERO LABS LTD UNIT IIIHIKMA PHARMACEUTICALS USA INCLANNETT CO INCMSN LABORATORIES PRIVATE LTDMYLAN LABORATORIES LTDNOVITIUM PHARMA LLCPH HEALTH LTDPHARMACEUTICAL ASSOCIATES INCRISING PHARMA HOLDINGS INCTARO PHARMACEUTICAL INDUSTRIES LTDUPSHER SMITH LABORATORIES LLCZAMEER PHARMACEUTICALS LLCZYDUS LIFESCIENCES GLOBAL FZE
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.